Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

c-fms expression in acute leukemias with complex phenotypes.

H Torrès1, P Dubreuil, F Falzetti

  • 1Unité 119 de l'INSERM, Institut Paoli-Calmettes, Marseille, France.

Leukemia
|October 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comprehensive genetic analysis in biliary tract cancer: a prospective single-center experience.

ESMO gastrointestinal oncology·2026
Same author

HLA-haploidentical hematopoietic stem cells transplantation with regulatory and conventional T-cell adoptive immunotherapy in pediatric patients with very high-risk acute leukemia.

Bone marrow transplantation·2023
Same author

Reply to 'development of severe pemphigus vulgaris following SARS-CoV-2 vaccination with BNT162b2' by Solimani F et al.

Journal of the European Academy of Dermatology and Venereology : JEADV·2022
Same author

Line-field confocal optical coherence tomography: a new tool for non-invasive differential diagnosis of pustular skin disorders.

Journal of the European Academy of Dermatology and Venereology : JEADV·2022
Same author

Operation and performance of the ATLAS Tile Calorimeter in Run 1.

The European physical journal. C, Particles and fields·2019
Same author

Search for electroweak production of supersymmetric particles in final states with two or three leptons at <math> </math> with the ATLAS detector.

The European physical journal. C, Particles and fields·2019

The c-fms/CSF-1 receptor is typically found in acute myeloid leukemia cells. However, this study reveals c-fms expression also occurs in some T-cell acute leukemias, challenging its exclusive role as a myeloid marker.

Area of Science:

  • Oncology
  • Hematology
  • Molecular Biology

Background:

  • The c-fms proto-oncogene product, the receptor for macrophage colony-stimulating factor (CSF-1), is consistently expressed in acute myeloid leukemia (AML) cells.
  • Previous studies indicated c-fms expression is linked to myeloid lineage differentiation in AML.

Purpose of the Study:

  • To investigate c-fms expression in a broader range of acute leukemias, including poorly differentiated myeloid leukemias, T-cell acute leukemias, B-cell acute leukemias, and biphenotypic leukemias.
  • To determine if c-fms expression is exclusively a marker for myeloid leukemias.

Main Methods:

  • Analysis of c-fms expression in various acute leukemia subtypes.
  • Examination of T cell receptor (TCR) gene rearrangements in conjunction with c-fms expression.

Related Experiment Videos

Main Results:

  • c-fms expression remains associated with myeloid origin in leukemias.
  • Expression of c-fms was also detected in a subset of acute leukemias with clonal rearrangements of the T cell receptor gene.
  • This suggests c-fms is not exclusively a marker for myeloid proliferations.

Conclusions:

  • While c-fms/CSF-1 receptor expression is strongly linked to myeloid leukemias, its presence in some T-cell acute leukemias indicates it is not a definitive myeloid-specific marker.
  • These findings broaden the understanding of c-fms expression patterns in hematological malignancies.